Academia

  • Email
  • Help

Information for you

On this page, you will find information on the European Medicines Agency’s (EMA) activities that are most relevant to academia, including news and events.

Learn more about the Agency's resources to support medicine development:

Human regulatory: Research and development
Veterinary regulatory: Research and development

Learn more about how EMA interacts with academia.

Featured information

News for academia

Events of interest

  • 19/04/2018

    CVMP

    European Medicines Agency veterinary medicines innovation day

    The purpose of the European Medicines Agency (EMA) veterinary medicines innovation day is to raise awareness and promote the support and measures that the Agency has to offer in the area of veterinary medicines innovation. The event is aimed at industry, including micro, small and medium-sized enterprises (SMEs) and veterinary consultants. The information provided will also be beneficial to academia, veterinary healthcare professionals and national competent authorities. ... Read more

  • 08/03/2018 - 09/03/2018

    EMA

    Second international awareness session for international regulators, academia and non-governmental organisations

    This two-day awareness session for international regulators , academia and non-governmental organisations (NGOs) will give an insight into how the European medicines regulatory network works, the role of European Medicines Agency (EMA), scientific aspects of EMA's work and its interaction with scientific experts. It will address topics including the role of experts and benefit-risk evaluation. It will also provide networking opportunities with academics, NGOs staff and regulators from and outside the European Union. The event will be broadcast live. EMA will publish further material after the event. ... Read more

  • 14/12/2017 - 15/12/2017

    CHMP

    Workshop on site and histology - Independent indications in oncology

    Biological drivers that define cancer course across anatomical sites and histologies offer an opportunity to select populations sensitive to specific drugs based on those drivers, independently of the specific site or histology. This workshop aims to provide an exchange of views from different stakeholders about situations where a site and histology-independent clinical development might be a viable option and the associated challenges in terms of drug development, benefit-risk evaluation and health-technology assessment. ... Read more

  • 06/02/2018

    EMA

    Extraordinary Management Board meeting: 6 February 2018

    The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance. ... Read more

  • 09/02/2018

    EMA

    Chimeric antigen receptor (CAR) T-cell therapy registries workshop

    The objective of this workshops is to facilitate the long-term follow up of CAR-T cell products in a real world setting and enable the generation of meaningful efficacy and safety data using haemato-oncological registries. It will aim to agree on implementable recommendations on core data elements to collect and other matters including patient consent, governance, quality assurance and registry interoperability as well as recommendations to optimise collaboration among registry holders, marketing authorisation holders and applicants and regulators. ... Read more

  • See all Events of interest

Information for:

Find information for...

Innovation_in_medicines

advanced_theraphy_medicinal_products

Orphan_designation

Scientific_advice_protocol_assistance